Inflammation Mistakes That Worsen POTS

Doctors who treat postural orthostatic tachycardia syndrome say patients often fight the wrong battle, chasing a racing heart rate while ignoring the inflammation quietly fueling it.

Quick Take

Dr. Nathan Keiser’s 2026 POTS treatment protocol targets immune and inflammatory drivers, not just heart rate symptoms.
Viral infections, chronic pathogens like Epstein-Barr virus and Lyme disease, and mold exposure are named triggers for symptom flares.
Medical literature backs the pattern, describing POTS as a multifactorial condition tied to post-viral and inflammatory pathways.
Roughly half of POTS cases follow an acute viral illness, according to published research.
Hydration and salt intake mistakes compound inflammation-driven symptoms, worsening blood flow problems.

The Protocol That Targets Inflammation First

Dr. Nathan Keiser built his 2026 POTS treatment approach around three layers most patients never address. He starts with basic metabolic and nutrient factors, then moves into immune and inflammatory drivers, and finally examines the neurovascular structures controlling brain blood flow and autonomic output. His point is simple. Treating symptoms alone misses the upstream problem still causing them.

Keiser identifies specific immune triggers he sees repeatedly in patients. Acute viral infections top the list, alongside chronic pathogens such as Epstein-Barr virus, Lyme disease, and mold exposure. These aren’t abstract risk factors. They represent ongoing immune activation that keeps the nervous system in a heightened, dysfunctional state, making standard POTS treatments less effective until the underlying driver gets addressed.

What the Broader Research Confirms

Published medical research supports the idea that infection and inflammation play an outsized role in POTS. One review found nearly half of POTS cases follow an acute viral illness, with researchers pointing to post-viral autonomic injury as a likely mechanism. Other studies link the condition to Epstein-Barr virus, influenza, and Lyme disease specifically, not just COVID-19.

Clinical reviewers describe POTS as a multifactorial syndrome rather than one single disease with one single cause. That framing matters. It means genetic predisposition, autoimmune activity, blood volume problems, and physical deconditioning can all stack on top of inflammation, and treatment that ignores any one piece leaves patients stuck. A separate autonomic study found elevated inflammatory markers showing up directly alongside reduced blood flow to the brain in POTS patients.

Where Hydration Mistakes Make Things Worse

Inflammation doesn’t operate alone. Poor hydration and inadequate salt intake amplify the same blood flow problems that inflammation causes, since POTS and chronic fatigue patients often run with blood volume roughly 25 percent below normal, well past the 15 percent threshold doctors consider a warning sign. Standard clinical consensus calls for two to three liters of fluid daily and 3 to 10 grams of salt, yet many patients undershoot both.

That gap matters because dehydration and inflammation feed the same downstream problem: reduced blood flow to the brain and poor autonomic control. A patient managing one issue while ignoring the other is treating half the disease. Keiser’s protocol treats hydration as foundational, not optional, precisely because it interacts directly with the inflammatory and neurovascular layers he targets.

Why This Matters for Patients Right Now

Patients living with POTS have spent years hearing that their condition is “just” a heart rate problem, something to manage with beta blockers and compression socks. The research says otherwise. Post-acute infection studies show patients with pre-existing POTS experienced measurable symptom deterioration after COVID-19 infection, with most requiring additional treatment and recovery stretching out for months.

That’s a meaningful shift in how the condition should be understood and treated. Chasing a number on a heart rate monitor while ignoring an active viral load, an unresolved tick-borne infection, or chronic mold exposure isn’t just incomplete care. It’s treating a symptom while the actual driver keeps running in the background, undermining every other intervention a patient tries.

The takeaway for anyone managing POTS is straightforward. Inflammation isn’t a side issue to mention at a follow-up appointment. It’s frequently the mechanism holding the whole condition in place, and addressing it alongside hydration, metabolic health, and neurovascular function gives patients a real shot at symptom relief instead of lifelong symptom management.